PPT-Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI

The BRIGHT4 Trial Gregg W Stone MD On behalf of Yaling Han and the BRIGHT4 investigators Disclosure Statement of Financial Interest Dr Gregg W Stone Specific to this topic None. Gregg W. Stone MD. Columbia University Medical Center Cardiovascular Research Foundation. Bivalirudin vs. Heparin + GPI (n=18,819). 30d TIMI major or minor bleeding by treatment and study . p < 0.0001. Nursing 201. Ms. Frasier. Summer 2014. Dimensional Analysis. Simple technique with a fancy name. Allows manipulation of units. Also referred as . factor label method . or the . unit factor method. Less errors. May 11, 2013. Objectives. Develop an approach for treating patients with iatrogenic coagulopathy. Understand recent changes in STEMI care. Review the ICH treatment protocol. Patient Care. Medical . Knowledge. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. Assist. Lect. Haider raheem. Digoxin. Digoxin is most useful for controlling ventricular response in persistent and permanent . atrial fibrillation . and . atrial flutter. . Digoxin also has a role in . Topic. pain. 1. res. pirato. ry drugs. 2. cardiac disease and drugs. 3. activated charcoal and . sorbotol. in poisoning. 4. pain. Acute pain. Pain immediately following an injury to the body is considered. Bernardo Cortese. Intv. ’ . Cardiology. , A.O. Fatebenefratelli. bcortese@gmail.com. b. ernardocortese.com. Stone GW . NEJM.. 2008;358:2218-30. . Mehran. R . Lancet. .. . 2009;374:1149-59. Stone . . suo. . annus. . horribilis. : un update . scientifico. Bernardo Cortese. Intv. ’ . Cardiology. , A.O. Fatebenefratelli. bcortese@gmail.com. HORIZONS AMI. 30 . Day and 1-Year All-Cause Mortality. Medication . Chart. Overview. This presentation will provide an overview of:. The layout of the WA Anticoagulation Medication Chart (WA AMC). The management of anticoagulants using the chart:. Low Molecular Weight Heparins (i.e. enoxaparin). During cardiopulmonary bypass procedures, systemic anticoagulation to prevent thrombosis in the patient as well as the circuit is utilized. Heparin is the most common agent used, but in selective cir This s tandard applies to inpatients aged over 16 years treated with intravenous unfractionated h eparin. Do not use t his standard for the management of intravenous unfractionated heparin in s Pulmonary Embolism Advanced Care Pathway. Low & . Intermediate-low risk PE. Low risk . S. table, . sPESI. = 0, no RV strain. Intermediate-low risk . Stable, . sPESI. ≥1, may have either RV strain OR elevated troponin (or neither). Dr Amy Thompson. ST5 infectious diseases/medical microbiology. Background and aims. TB service sees many patients who have undergone repeated neck node aspiration/biopsy. Delay in diagnosis. Delay in treatment.